Blog
- December 10, 2021
Insights from two decades of applied use More than 20 years ago, LabVantage made a commitment to the life science market by creating a research initiative of our own. At...
- May 14, 2021
Data integrity had already become a top priority for the clinical and life science (pharma, biopharma, med device) sectors before the outbreak of COVID-19. Data Integrity Guidelines New guidance had...
- May 2, 2021
If you are wondering how labs in other business sectors managed the challenges of the global pandemic, here’s a quick rundown of what others have been facing, some of the...
- November 13, 2020
One of the most important things we collectively need to harness and exploit in order to safely & effectively navigate through the pandemic is data. This is true of everyone...
- June 8, 2020
By early May, the LIMS architect for an Ivy League health system’s biobank and his team of ten felt like they’d been hit by a train. COVID-19 research had accelerated...
- May 15, 2019
Molecular and clinical diagnostics labs are facing increasingly large sample & data volumes and more complicated challenges surrounding compliance. In addition, there is a critical need for greater system integration...
- April 30, 2019
What’s a Biobank? Easy – a collection of data and samples. And what is a biobank’s core function? Managing those samples and compiling that data (depending on the biorepository’s focus,...
- January 7, 2019
Biobanking: More – Much More – Data On at least one key trend, every prediction and prognostication about the future of biobanking arrives at a consensus. The sheer volume of...
